Marks and Spencer Group (MKS) Given New GBX 275 Price Target at Goldman Sachs Group

Marks and Spencer Group (LON:MKS) had its price objective decreased by Goldman Sachs Group from GBX 330 ($4.44) to GBX 275 ($3.70) in a research note published on Monday morning. Goldman Sachs Group currently has a sell rating on the retailer’s stock.

Several other research firms have also issued reports on MKS. Deutsche Bank restated a hold rating and issued a GBX 345 ($4.64) price target on shares of Marks and Spencer Group in a research report on Friday, October 6th. Jefferies Group restated a buy rating and issued a GBX 420 ($5.65) price target on shares of Marks and Spencer Group in a research report on Tuesday, September 26th. J P Morgan Chase & Co restated an underweight rating and issued a GBX 285 ($3.84) price target on shares of Marks and Spencer Group in a research report on Tuesday, October 31st. Canaccord Genuity restated a hold rating and issued a GBX 375 ($5.05) price target on shares of Marks and Spencer Group in a research report on Wednesday, November 8th. Finally, Barclays restated an overweight rating and issued a GBX 370 ($4.98) price target on shares of Marks and Spencer Group in a research report on Thursday, November 9th. Nine analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of GBX 350.70 ($4.72).

Marks and Spencer Group (LON MKS) traded down GBX 0.70 ($0.01) during midday trading on Monday, hitting GBX 315.50 ($4.25). 10,810,036 shares of the company were exchanged, compared to its average volume of 10,450,000. Marks and Spencer Group has a fifty-two week low of GBX 296.30 ($3.99) and a fifty-two week high of GBX 397.80 ($5.35).

Marks and Spencer Group (LON:MKS) last posted its quarterly earnings data on Wednesday, November 8th. The retailer reported GBX 10.70 ($0.14) EPS for the quarter, beating the Zacks’ consensus estimate of GBX 9.60 ($0.13) by GBX 1.10 ($0.01). Marks and Spencer Group had a net margin of 1.65% and a return on equity of 5.62%. The business had revenue of GBX 512.56 billion for the quarter.

The company also recently disclosed a dividend, which will be paid on Friday, January 12th. Shareholders of record on Thursday, November 16th will be given a dividend of GBX 6.80 ($0.09) per share. This represents a yield of 2.13%. The ex-dividend date is Thursday, November 16th.

In other news, insider Archie Norman acquired 33,000 shares of the stock in a transaction on Wednesday, November 22nd. The shares were purchased at an average cost of GBX 300 ($4.04) per share, for a total transaction of £99,000 ($133,243.61).

ILLEGAL ACTIVITY NOTICE: “Marks and Spencer Group (MKS) Given New GBX 275 Price Target at Goldman Sachs Group” was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2017/12/05/marks-and-spencer-group-mks-given-new-gbx-275-price-target-at-goldman-sachs-group.html.

About Marks and Spencer Group

Marks and Spencer Group plc (M&S) is a retailer in the United Kingdom, with over 1,380 stores around the world. The Company is the holding company of the Marks & Spencer Group of companies. The Company operates through two segments: UK and International. The UK segment consists of the United Kingdom retail business and the United Kingdom franchise operations.

Analyst Recommendations for Marks and Spencer Group (LON:MKS)

What are top analysts saying about Marks and Spencer Group plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Marks and Spencer Group plc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit